Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Fujian Cosunter Pharmaceutical Co., Ltd.
—
Fujian Cosunter Pharmaceutical Co., Ltd. is led by CEO Guoping Li, employs 715 people, headquartered in Fuzhou, CN, publicly traded since 2015.
Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) stock trades at $79.90 with a market capitalization of $14.36B. The stock is valued at a negative price-to-earnings (P/E) ratio of -65.18, reflecting a net loss over the last twelve months, price-to-book of 65.02, price-to-sales of 33.57. Over the past 52 weeks the stock has ranged between $73.60 and $149.00, and currently trades 46.4% below its 52-week high.
On profitability, Fujian Cosunter Pharmaceutical Co., Ltd. generates a return on equity (ROE) of -82.74% (negative, reflecting a net loss), an operating margin of -17.01%, a net profit margin of -51.28%.
Official website: www.cosunter.com
Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) — frequently asked questions
What is Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) stock price today?
Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) is currently trading at $79.90, down 2.18% today.
What is 300436.SZ P/E ratio?
Fujian Cosunter Pharmaceutical Co., Ltd.'s P/E ratio is -65.18. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 300436.SZ return on equity (ROE)?
Fujian Cosunter Pharmaceutical Co., Ltd.'s return on equity (ROE) is -82.74%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Fujian Cosunter Pharmaceutical Co., Ltd.'s market cap?
Fujian Cosunter Pharmaceutical Co., Ltd. has a market capitalization of $14.36B.
Does 300436.SZ pay a dividend?
Fujian Cosunter Pharmaceutical Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 300436.SZ carry?
Fujian Cosunter Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 1.75. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300436.SZ's profit margin?
Fujian Cosunter Pharmaceutical Co., Ltd. reports a net profit margin of -51.28% — the share of revenue left after every cost, including tax and interest.
What sector is 300436.SZ in?
Fujian Cosunter Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300436.SZ listed on?
Fujian Cosunter Pharmaceutical Co., Ltd. trades on SHZ under the ticker 300436.SZ.
What is 300436.SZ's 52-week range?
Over the last year Fujian Cosunter Pharmaceutical Co., Ltd. has traded between $73.60 and $149.00.
Related — Stocks
Popular Stocks
Screens 300436.SZ currently matches
On the figures above, Fujian Cosunter Pharmaceutical Co., Ltd. passes the filters for 4 of our ready-made screens, among them Large Cap Stocks, Stocks Under $100, High Gross Margin Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.